Scout | Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)

This grant aims to support research that strengthens the basis for future therapies in areas related to diabetes, obesity, endocrinology, metabolism, digestive and liver diseases, nutrition, kidney and urological diseases, and blood disorders. It encourages applicants to align their work with the research priorities of the National Institute of Diabetes and Digestive and Kidney Diseases and to…

Source

Agency: National Institutes of Health

Sub-agency: National Institute of Diabetes and Digestive and Kidney Diseases

Program: SBIR

Dates

Opportunity Released: February 4, 2022

Open for Submission: February 4, 2022

Submission Deadline: January 7, 2025

Application Window Closes: January 7, 2025

Keywords

translational research

therapeutics discovery

diabetes

digestive diseases

obesity

endocrinology

metabolism

liver diseases

kidney diseases

hematology

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers